Optimization of corticosteroid induced osteoporosis in ovariectomized sheep

Summary

During osteoporosis induction in sheep, side effects of the steroids were observed in previous studies. The aim of this study was to improve the induction regimen consisting of ovariectomy, calcium/vitamin D- restricted diet and methylprednisolone (-MP)- medication with respect to the bone metabolism and to reduce the adverse side effects. Thirty-six ewes (age 6.5 ± 0.6 years) were divided into four MP-administration groups (n=9) with a total dose of 1800 mg MP: group 1: 20 mg/day, group 2: 60 mg/ every third day, group 3: 3x 500 mg and 1x 300 mg at intervals of three weeks, group 4: weekly administration, starting at 70 mg and weekly reduction by 10 mg. After double-labelling with Calcein Green and Xylenol Orange, bone biopsy specimens were taken from the iliac crest (IC) at the beginning and four weeks after the last MP injection, and additionally from the vertebral body (VB) at the end of the experiment. Bone samples were processed into stained and fluorescent sections, static and dynamic measurements were performed. There were no significant differences for static parameters between the groups initially. The bone perimeter and the bone area values were significantly higher in the VB than in the IC (Pm: 26%, p<0.0001, Ar: 11%, p<0.0166). A significant decrease (20%) of the bone area was observed after corticosteroid- induced osteoporosis (p<0.0004). For the dynamic parameters, no significant difference between the groups was found. Presence of Calcein Green and Xylenol Orange labels were noted in 50% of the biopsies in the IC, 100% in the VB. Group 3 showed the lowest prevalence of adverse side effects. The bone metabolism changes were observed in all four groups, and the VB bone metabolism was higher when compared to the IC. In conclusion, when using equal amounts of steroids adverse side effects can be reduced by decreasing the number of administrations without reducing the effect regarding corticosteroid- induced osteoporosis. This information is useful to reduce the discomfort of the animals in this sheep model of corticosteroid-induced osteoporosis.

Keywords

Osteoporosis - animal model - sheep - corticosteroids - bone histomorphometry

• References

• 1 Goltzman D. The contribution of basic science to the field of osteoporosis. Osteoporos Int. 2000 Suppl. 2 S43.
• 2 Swiontkowski MF, Harrington RM, Keller TS. et al. Torsion and bending analysis of internal fixation techniques for femoral neck fractures: the role of implant design and bone density. J Orthop Res 1987; 5: 433-444.
• 3 Newman E, Turner AS, Wark JD. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 1995; 16 (4 Suppl) 277S-284S.
• 4 Pastoureau P, Arlot ME, Caulin F. Effects of oophorectomy on biochemical and histological indices of bone turnover in ewes. J Bone Miner Res. 1989 4. (Suppl. 1) 58.
• 5 Chavassieux P, Pastoureau P, Chapuy MC. et al. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histo- morphometric study. Osteoporos Int 1993; 3: 97-102.
• 6 Chavassieux P, Buffet A, Vergnaud P. et al. Short- term effects of corticosteroids on trabecular bone remodeling in old ewes. Bone 1997; 20: 451-455.
• 7 Lill CA, Fluegel AK, Schneider E. Sheep model for fracture treatment in osteoporotic bone: apilot study about different induction regimens. J Orthop Trauma 2000; 14: 559-565.
• 8 Lill CA, Gerlach UV, Eckhardt C. et al. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int 2002; 13: 407-414.
• 9 Lill CA, Fluegel AK, Schneider E. Effect of ova- riectomy, malnutrition and glucocorticoid application on bone properties in sheep: a pilot study. Osteoporos Int 2002; 13: 480-486.
• 10 Parfitt AM, Drezner MK, Glorieux FH. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2: 595-610.
• 11 Lill CA, Winterstein E, Eckhardt C. et al. Quantification of histomorphometric and structural bone changes in a sheep model for fracture treatment in osteoporotic bone. Vet Comp Orthop Traumatol 2003; 16: 243-249.
• 12 Dempster Dempster. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 1989; 4: 137-141.
• 13 Muller R, Van Campenhout H, Van Damme B. et al. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998; 23: 59-66.
• 14 Chavassieux P, Garnero P, Duboeuf F. et al. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: abiochemical, histomor- phometric, and densitometric study. J Bone Miner Res 2001; 16: 89-96.
• 15 Lespessailles E, Roux JP, Benhamou CL. et al. Fractal analysis ofbone texture on os calcis radiographs compared with trabecular microarchitecture analyzed by histomorphometry. Calcif Tissue Int 1998; 63: 121-125.
• 16 Lespessailles E, Siroux V, Poupon S. et al. Long- term corticosteroid therapy induces mild changes in trabecular bone texture. J Bone Miner Res 2000; 15: 747-753.
• 17 Selby PL, Halsey JP, Adams KR. et al. Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000; 15: 952-956.
• 18 Williamson LH. Caseous lymphadenitis in small ruminants. Vet Clin North Am Food Anim Pract 2001; 17: 359-371 VII.